Treatment of aromatase inhibitor therapy-related osteoporosis

Details Treatment of aromatase inhibitor therapy-related osteoporosis Treatment of aromatase inhibitor therapy-related osteoporosis

A - Human Necessities

61

K

A61K 31/4184 (2006.01) A61K 31/4196 (2006.01) A61K 31/55 (2006.01) A61K 31/565 (2006.01) A61K 31/566 (2006.01)

Patent

CA 2552725

This invention relates to the use bazedoxifene (1-[4-(2-azepan-1-yl-ethoxy)- benzyl]-2-(4-hydroxy-phenyl)-3-methyl- 1H-indol-5-ol) in the treatment or inhibition of osteoporosis and osteopenia related to aromatase inhibitor therapy.

L'invention concerne l'utilisation de bazedoxifène (1-[4-(2-azépan-1-yl-éthoxy)-benzyl]-2-(4-hydroxy-phényl)-3-méthyl- 1H-indol-5-ol) dans le traitement ou l'inhibition de l'ostéoporose et l'ostéopénie liée au traitement de l'inhibiteur de l'aromatase.

Affiliated with

Also associated with

Rating

Treatment of aromatase inhibitor therapy-related osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of aromatase inhibitor therapy-related osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of aromatase inhibitor therapy-related osteoporosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1907635